Artemisinin resistance: current status and scenarios for containment - Test2 - elhamkhani - TriplyDB

Artemisinin resistance: current status and scenarios for containment

Artemisinin resistance: current status and scenarios for containment

http://www.wikidata.org/entity/Q21032505

about

Advances and challenges in malaria vaccine development Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum Artemisinin-resistant malaria: research challenges, opportunities, and public health implications Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions A "reverse pharmacology" approach for developing an anti-malarial phytomedicine.Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study Artemisinin anti-malarial drugs in China Ethical aspects of malaria control and research The counterfeit anti-malarial is a crime against humanity: a systematic review of the scientific evidence An evolutionary perspective on the kinome of malaria parasites Choline analogues in malaria chemotherapy Designing the next generation of medicines for malaria control and eradication Drug-resistant malaria in Sudan: A review of evidence and scenarios for the future Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems Recent advances in malaria drug discovery Lipoic acid metabolism of Plasmodium--a suitable drug target A novel Plasmodium falciparum rhoptry associated adhesin mediates erythrocyte invasion through the sialic-acid dependent pathway Asparagine requirement in Plasmodium berghei as a target to prevent malaria transmission and liver infections.Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential New N-Acetyltransferase Fold in the Structure and Mechanism of the Phosphonate Biosynthetic Enzyme FrbF Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity Crystal structures of Plasmodium falciparum cytosolic tryptophanyl-tRNA synthetase and its potential as a target for structure-guided drug design Dynamic Structure and Inhibition of a Malaria Drug Target: Geranylgeranyl Diphosphate Synthase Malaria Parasite-Infected Erythrocytes Secrete PfCK1, the Plasmodium Homologue of the Pleiotropic Protein Kinase Casein Kinase 1 Involvement of Plasmodium falciparum protein kinase CK2 in the chromatin assembly pathway Characterization of Precursor PfHsp60 in Plasmodium falciparum Cytosol during Its Asexual Development in Human Erythrocytes Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways Atypical mitogen-activated protein kinase phosphatase implicated in regulating transition from pre-S-Phase asexual intraerythrocytic development of Plasmodium falciparum In silico characterization of an atypical MAPK phosphatase of Plasmodium falciparum as a suitable target for drug discovery SAM domain-dependent activity of PfTKL3, an essential tyrosine kinase-like kinase of the human malaria parasite Plasmodium falciparum Malaria Parasites: The Great Escape High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes Domestic trends in malaria research and development in China and its global influence A research agenda for malaria eradication: drugs The next opportunity in anti-malaria drug discovery: the liver stage Further improvements of the P. falciparum humanized mouse model Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action

P2860

Q21032463-B486E829-9F2E-45E9-AF3D-E09306D31CBB Q21032477-40FBF59A-EEB9-4F52-9E02-E3F7E1F95537 Q21032532-D53D2A8F-746B-495B-87FA-FE3A15E9C43F Q21034069-771595DF-145C-4533-AD9D-964FBF15EEC8 Q21034114-58A5EF13-FE17-4CF5-9151-FC84BE296395 Q24198103-76DD29E6-0FDA-4ABB-B11E-8C2AF6CBC3FC Q24598695-D71FB0E7-BF70-4B56-B260-BEF123A97C13 Q26752394-C8C38287-47D2-479C-8712-2751560E3125 Q26773470-20645096-B754-4A78-82A3-B4351EB5B44D Q26828002-FF54C33E-A5CF-45BF-9C3F-2C0CC80C54CE Q26829254-FD10E74A-44B5-4C22-91FF-8AE159D41296 Q26851323-AFB1E1F4-FD45-4D01-A449-F9C6572B11CE Q26859195-C8F62D26-54CD-4EE0-9862-9CE398E80BA6 Q26860010-6251EFBD-E2CD-4902-95A6-991EF553D383 Q27000750-FE5D2C1E-52DA-460B-AE1C-96B7A746A81A Q27010534-F521B7D7-2C3A-4838-8992-0D280AE01177 Q27026939-9CFA2A5E-81F2-4999-8132-9CDFF331787A Q27230077-391568A0-E891-43C1-A232-6E7203D7CF96 Q27319073-CBCBACD1-5B84-42FE-A80C-3689CB49FC3C Q27670499-990DB076-EEF2-4405-9252-F69D12CA58F0 Q27671948-0447FE20-58E5-4AA5-A036-15238416BF01 Q27677853-DBD0E776-78F3-4306-B7E8-E05B10F80A5E Q27678084-B3B3179D-CECD-454E-BE56-9DF054D30340 Q27727743-1566798E-EEA2-4184-9CB5-F496240578B5 Q27973591-F3CE023B-812C-423E-819B-CE8DFDD66F84 Q27973592-93BFC99C-918F-4AAF-AD91-7D7B8BE2F428 Q27973658-4A418038-48C4-49AF-AEE9-009BAF6492A4 Q27974683-E637F938-0C35-4EFC-9C69-961DB72945D7 Q27974726-9A8A793D-3C13-4283-BBAB-9B7AAFCAD22C Q27974727-50823F50-2081-4118-AC2F-C23063D4D927 Q27974774-634EE25D-FDC2-4EF1-B657-8F8A52F36F4B Q28080325-E9B83F8E-C178-4BD9-9A54-0351D14A5B25 Q28125930-82A8EDF5-5C53-4DDE-823A-948C2515E40A Q28125936-4D98C0EC-4AD4-4D8E-A2AE-B23545F332A6 Q28365208-62279418-1FA2-4648-885B-0056C624A889 Q28476806-9A1C9C0C-75B0-4877-B835-E6BD32D8F7EC Q28477177-092A9764-F78E-47EB-A98D-EBD314DD4A99 Q28477591-DAEC8FE9-6B1F-4DEF-8109-CACFF4FCC63B Q28477892-8F72C991-6C0B-408F-A54C-DE391336D6A9 Q28481199-408A1B5D-C8DC-468A-BD96-65093E5D12E4

P2860

Artemisinin resistance: current status and scenarios for containment

http://www.wikidata.org/entity/Q21032505

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Artemisinin resistance: current status and scenarios for containment

@ast

Artemisinin resistance: current status and scenarios for containment

@en

Artemisinin resistance: current status and scenarios for containment

@en-gb

Artemisinin resistance: current status and scenarios for containment

@nl

type

label

Artemisinin resistance: current status and scenarios for containment

@ast

Artemisinin resistance: current status and scenarios for containment

@en

Artemisinin resistance: current status and scenarios for containment

@en-gb

Artemisinin resistance: current status and scenarios for containment

@nl

prefLabel

Artemisinin resistance: current status and scenarios for containment

@ast

Artemisinin resistance: current status and scenarios for containment

@en

Artemisinin resistance: current status and scenarios for containment

@en-gb

Artemisinin resistance: current status and scenarios for containment

@nl

P1433

Q21032505-82EB5492-A3E7-423E-9E7C-54CDDAE89D85

P1476

Q21032505-73C09AB5-4E9F-4F1C-B770-EDDA75230094

P2093

Q21032505-22F1CBCC-ECAE-4496-9491-1315FCA17FD0

Q21032505-31944882-1421-4FE8-BD1C-D69395452CFF

Q21032505-49877E81-52E0-4551-97D6-41C293F0C986

Q21032505-561D8F53-98BE-44A4-9568-23DECB33020F

Q21032505-E47A91C1-87B9-4186-AA82-0344916D5364

P2888

Q21032505-7862D869-007C-47C0-8A6C-8FE07750A7DB

P304

Q21032505-7156D507-B3BE-4E69-B60E-56CE21EE2CDC

P31

Q21032505-5AC23179-A56B-4F64-ABA3-3CA931B2F69F

P3181

Q21032505-28262479-5969-425A-8373-C7F17D8CFEF7

P356

Q21032505-D792A28F-31BF-4928-8C16-149EE9278CFD

P407

Q21032505-11FDE51C-2FA9-4DDE-9CB9-54A4BEB767CD

P433

Q21032505-DD0DC842-8E9B-4FD2-A224-666A00560975

P478

Q21032505-31DFD094-274A-47BA-A4D2-6BA7E36F5F46

P50

Q21032505-08A2E7EE-AD3C-4DFC-AEAA-8DF5924243B9

Q21032505-EF5870E7-1468-4277-9CFC-1543270477C0

P577

Q21032505-5E0E5A21-326F-4A7C-AAF2-E0D88FBC7486

P5875

Q21032505-13A5B65C-E2BF-4B16-9F72-216C76C6DB02

P6179

Q21032505-D9E13C0B-8A4B-44DE-B42C-991DD7D492D9

P698

Q21032505-18117124-F516-4BE5-A121-EDC1FEDDEC0F

P921

Q21032505-02F23A8F-3589-4F0B-A440-129FB09D3314

P3181

P356

P1433

Nature Reviews Microbiology

P1476

Artemisinin resistance: current status and scenarios for containment

@en

P2093

Arjen M. Dondorp

http://www.w3.org/2001/XMLSchema#string

Duong Socheat

http://www.w3.org/2001/XMLSchema#string

Lisa White

http://www.w3.org/2001/XMLSchema#string

Nicholas P.J. Day

http://www.w3.org/2001/XMLSchema#string

Shunmay Yeung

http://www.w3.org/2001/XMLSchema#string

P2888

P304

272-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

17428

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NRMICRO2331

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Lorenz von Seidlein

P577

2010-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41809165

http://www.w3.org/2001/XMLSchema#string

P6179

1003849904

http://www.w3.org/2001/XMLSchema#string

P698

20208550

http://www.w3.org/2001/XMLSchema#string

P921